Anti-aging Drugs Market Size, Clinical Pipeline Trends and Forecast to 2031 at 11.9% CAGR

Market Summary -

The global market for Anti-aging Drugs was estimated to be worth US$ 11030 million in 2024 and is forecast to a readjusted size of US$ 23970 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.

Accourding to QY Research has released a new publication titled "Global Anti-aging Drugs Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031." This comprehensive study provides an in-depth evaluation of the worldwide Anti-aging Drugs industry, uncovering the major forces influencing market growth and delivering high-value insights for investors, industry leaders, and strategic decision-makers. The report examines critical elements such as market dynamics, evolving technologies, segmentation trends, regional developments, and the competitive landscape. With data backed by rigorous research and expert interpretation, it offers an authoritative guide to understanding the macroeconomic and microeconomic factors reshaping the global market.

Get Full PDF Sample Copy of the Report: (Including Full TOC, Tables & Charts): https://qyresearch.in/request-sample/pharma-healthcare-anti-aging-drugs-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Anti-aging Drugs cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The anti-aging drugs market is propelled by several compelling factors. Most notably, the global population is aging rapidly-by 2050, the number of people aged 65 and above is projected to reach around 1.5-2.1 billion. This demographic shift fuels demand for therapies targeting age-related diseases like cardiovascular disorders, diabetes, neurodegenerative conditions, osteoporosis, and skin photoaging . Meanwhile, breakthroughs in biotechnology-spanning CRISPR, senolytics, mTOR inhibitors, NAD+ boosters, regenerative medicine, gene-editing, and AI-enabled drug discovery-are unlocking new therapeutic avenues. Rising disposable incomes, especially in emerging markets, and heightened consumer demand for wellness and aesthetic solutions further support market expansion.

Nevertheless, the sector faces significant hurdles. Chief among them are the exorbitant research and R&D costs-developing these drugs typically involves multi-year investment, expensive clinical trials, and complex regulatory approval procedures, often costing upwards of $1 billion . Regulatory ambiguity is another barrier: aging is not formally recognized as a disease, and oversight for aging-related therapies remains unclear, delaying approvals . Limited clinical evidence, short-term trial data, and safety concerns (e.g., off-label use, side effects, lack of biomarkers) hinder adoption

Market Drivers, Challenges & Restraints -

This section outlines the various elements influencing the trajectory of the Anti-aging Drugs market:

Key Growth Drivers -

- Supportive policy frameworks and regulatory reforms
- Advancement in product innovation and technological breakthroughs
- Growing demand in emerging application areas
- Shift in global supply chain structures

Restraints & Challenges -

- Regulatory uncertainties
- Competitive pricing pressures
- Operational risks
- Market-entry barriers

Market Segmentation and Regional -

By Type

Dermal Fillers
Botulinum Toxin
Others

By Application

Hospital
Beauty Parlor
Others

Regional Analysis -

✔ North America (U.S., Canada, China)
✔ Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
✔ Asia-Pacific (Japan, South Korea, China Taiwan, Southeast Asia, India)
✔ Middle East, Africa, Latin America (Brazil, Mexico, Turkey, Israel, GCC Countries)

The analysis spans from 2024 (base year) to 2031 (forecast period).

Major Company Included: -

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Request for Pre-Order / Enquiry Link:https://qyresearch.in/pre-order-inquiry/pharma-healthcare-anti-aging-drugs-market-share-and-ranking-overall-sales-and-demand-forecast-2025-2031

Why should you purchase this report?

Purchasing this report provides you with a comprehensive and data-driven understanding of the market landscape, enabling informed business decisions and strategic planning. The report comes with free customization based on client requirements, including a country-level breakdown of any five countries of your choice and a competitive analysis of segment revenue by key market players. With detailed insights into market trends, growth drivers, challenges, competitive dynamics, and emerging opportunities, this report equips stakeholders, manufacturers, and investors with actionable intelligence to identify profitable prospects, optimize operations, and maintain a competitive edge in the industry.

How Can the Research Study Help your Business?

✔ The information presented in the Anti-aging Drugs report helps your decision makers to become prudent and make the best business choices.
✔ The report enables you to see the future of the global Anti-aging Drugs market and accordingly take decisions that will be in the best interest of your business.
✔ It offers you a forward-looking perspective of the global Anti-aging Drugs market drivers and how you can secure significant market gains in the near future.
✔ It provides SWOT analysis of the global Anti-aging Drugs market along with useful graphics and detailed statistics providing quick information about the market's overall progress throughout the forecast period.
✔ It also assesses the changing competitive dynamics of the global Anti-aging Drugs market using pin-point evaluation.

Key Questions Answered in the Report -

✔ What is the size and estimated growth rate of the global and regional Anti-aging Drugs market?
✔ Which countries are expected to display the strongest growth?
✔ Which region will dominate the market throughout the forecast period?
✔ What are the main factors driving or restraining market expansion?
✔ What technological advancements are shaping future demand?
✔ Where are the key opportunities for new entrants and established players?
✔ Which companies currently hold the highest market share?
✔ How will market dynamics evolve from 2025 to 2031?

Table of Contents - Major Key Points:

1 Market Overview
1.1 Anti-aging Drugs Product Introduction
1.2 Global Anti-aging Drugs Market Size Forecast
1.2.1 Global Anti-aging Drugs Sales Value (2020-2031)
1.2.2 Global Anti-aging Drugs Sales Volume (2020-2031)
1.2.3 Global Anti-aging Drugs Sales Price (2020-2031)
1.3 Anti-aging Drugs Market Trends & Drivers
1.3.1 Anti-aging Drugs Industry Trends
1.3.2 Anti-aging Drugs Market Drivers & Opportunity
1.3.3 Anti-aging Drugs Market Challenges
1.3.4 Anti-aging Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-aging Drugs Players Revenue Ranking (2024)
2.2 Global Anti-aging Drugs Revenue by Company (2020-2025)
2.3 Global Anti-aging Drugs Players Sales Volume Ranking (2024)
2.4 Global Anti-aging Drugs Sales Volume by Company Players (2020-2025)
2.5 Global Anti-aging Drugs Average Price by Company (2020-2025)
2.6 Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
2.7 Key Manufacturers Anti-aging Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
2.9 Anti-aging Drugs Market Competitive Analysis
2.9.1 Anti-aging Drugs Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-aging Drugs Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Dermal Fillers
3.1.2 Botulinum Toxin
3.1.3 Others
3.2 Global Anti-aging Drugs Sales Value by Type
3.2.1 Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Anti-aging Drugs Sales Value, by Type (2020-2031)
3.2.3 Global Anti-aging Drugs Sales Value, by Type (%) (2020-2031)
3.3 Global Anti-aging Drugs Sales Volume by Type
3.3.1 Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Anti-aging Drugs Sales Volume, by Type (2020-2031)
3.3.3 Global Anti-aging Drugs Sales Volume, by Type (%) (2020-2031)
3.4 Global Anti-aging Drugs Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Beauty Parlor
4.1.3 Others
4.2 Global Anti-aging Drugs Sales Value by Application
4.2.1 Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Anti-aging Drugs Sales Value, by Application (2020-2031)
4.2.3 Global Anti-aging Drugs Sales Value, by Application (%) (2020-2031)
4.3 Global Anti-aging Drugs Sales Volume by Application
4.3.1 Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Anti-aging Drugs Sales Volume, by Application (2020-2031)
4.3.3 Global Anti-aging Drugs Sales Volume, by Application (%) (2020-2031)
4.4 Global Anti-aging Drugs Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Anti-aging Drugs Sales Value by Region
5.1.1 Global Anti-aging Drugs Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Anti-aging Drugs Sales Value by Region (2020-2025)
5.1.3 Global Anti-aging Drugs Sales Value by Region (2026-2031)
5.1.4 Global Anti-aging Drugs Sales Value by Region (%), (2020-2031)
5.2 Global Anti-aging Drugs Sales Volume by Region
5.2.1 Global Anti-aging Drugs Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Anti-aging Drugs Sales Volume by Region (2020-2025)
5.2.3 Global Anti-aging Drugs Sales Volume by Region (2026-2031)
5.2.4 Global Anti-aging Drugs Sales Volume by Region (%), (2020-2031)
5.3 Global Anti-aging Drugs Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Anti-aging Drugs Sales Value, 2020-2031
5.4.2 North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Anti-aging Drugs Sales Value, 2020-2031
5.5.2 Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-aging Drugs Sales Value, 2020-2031
5.6.2 Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Anti-aging Drugs Sales Value, 2020-2031
5.7.2 South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-aging Drugs Sales Value, 2020-2031
5.8.2 Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Anti-aging Drugs Sales Value and Sales Volume
6.2.1 Key Countries/Regions Anti-aging Drugs Sales Value, 2020-2031
6.2.2 Key Countries/Regions Anti-aging Drugs Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Anti-aging Drugs Sales Value, 2020-2031
6.3.2 United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Anti-aging Drugs Sales Value, 2020-2031
6.4.2 Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Anti-aging Drugs Sales Value, 2020-2031
6.5.2 China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.5.3 China Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Anti-aging Drugs Sales Value, 2020-2031
6.6.2 Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Anti-aging Drugs Sales Value, 2020-2031
6.7.2 South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-aging Drugs Sales Value, 2020-2031
6.8.2 Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Anti-aging Drugs Sales Value, 2020-2031
6.9.2 India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
6.9.3 India Anti-aging Drugs Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 AbbVie Anti-aging Drugs Product Offerings
7.1.5 AbbVie Recent Development
7.2 Galderma
7.2.1 Galderma Company Information
7.2.2 Galderma Introduction and Business Overview
7.2.3 Galderma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Galderma Anti-aging Drugs Product Offerings
7.2.5 Galderma Recent Development
7.3 LG Life Sciences
7.3.1 LG Life Sciences Company Information
7.3.2 LG Life Sciences Introduction and Business Overview
7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 LG Life Sciences Anti-aging Drugs Product Offerings
7.3.5 LG Life Sciences Recent Development
7.4 Merz
7.4.1 Merz Company Information
7.4.2 Merz Introduction and Business Overview
7.4.3 Merz Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merz Anti-aging Drugs Product Offerings
7.4.5 Merz Recent Development
7.5 Medytox
7.5.1 Medytox Company Information
7.5.2 Medytox Introduction and Business Overview
7.5.3 Medytox Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Medytox Anti-aging Drugs Product Offerings
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Introduction and Business Overview
7.6.3 Hugel Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hugel Anti-aging Drugs Product Offerings
7.6.5 Hugel Recent Development
7.7 Croma-Pharma
7.7.1 Croma-Pharma Company Information
7.7.2 Croma-Pharma Introduction and Business Overview
7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Croma-Pharma Anti-aging Drugs Product Offerings
7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Company Information
7.8.2 Beijing IMEIK Introduction and Business Overview
7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Beijing IMEIK Anti-aging Drugs Product Offerings
7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Information
7.9.2 Bloomage Bio Introduction and Business Overview
7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Bloomage Bio Anti-aging Drugs Product Offerings
7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Company Information
7.10.2 Elravie (Humedix) Introduction and Business Overview
7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Elravie (Humedix) Anti-aging Drugs Product Offerings
7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Company Information
7.11.2 Cleviel (Pharma Research Products) Introduction and Business Overview
7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
7.12.1 Haohai Biological Company Information
7.12.2 Haohai Biological Introduction and Business Overview
7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Haohai Biological Anti-aging Drugs Product Offerings
7.12.5 Haohai Biological Recent Development
7.13 Teoxane
7.13.1 Teoxane Company Information
7.13.2 Teoxane Introduction and Business Overview
7.13.3 Teoxane Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Teoxane Anti-aging Drugs Product Offerings
7.13.5 Teoxane Recent Development
7.14 Sinclair
7.14.1 Sinclair Company Information
7.14.2 Sinclair Introduction and Business Overview
7.14.3 Sinclair Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Sinclair Anti-aging Drugs Product Offerings
7.14.5 Sinclair Recent Development
7.15 Suneva Medical
7.15.1 Suneva Medical Company Information
7.15.2 Suneva Medical Introduction and Business Overview
7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Suneva Medical Anti-aging Drugs Product Offerings
7.15.5 Suneva Medical Recent Development
7.16 CG Bio
7.16.1 CG Bio Company Information
7.16.2 CG Bio Introduction and Business Overview
7.16.3 CG Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 CG Bio Anti-aging Drugs Product Offerings
7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Information
7.17.2 SciVision Biotech Introduction and Business Overview
7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 SciVision Biotech Anti-aging Drugs Product Offerings
7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
7.18.1 Prollenium Company Information
7.18.2 Prollenium Introduction and Business Overview
7.18.3 Prollenium Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Prollenium Anti-aging Drugs Product Offerings
7.18.5 Prollenium Recent Development
7.19 Bohus BioTech
7.19.1 Bohus BioTech Company Information
7.19.2 Bohus BioTech Introduction and Business Overview
7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Bohus BioTech Anti-aging Drugs Product Offerings
7.19.5 Bohus BioTech Recent Development
7.20 Caregen
7.20.1 Caregen Company Information
7.20.2 Caregen Introduction and Business Overview
7.20.3 Caregen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Caregen Anti-aging Drugs Product Offerings
7.20.5 Caregen Recent Development
7.21 Ipsen
7.21.1 Ipsen Company Information
7.21.2 Ipsen Introduction and Business Overview
7.21.3 Ipsen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Ipsen Anti-aging Drugs Product Offerings
7.21.5 Ipsen Recent Development
7.22 LIBP
7.22.1 LIBP Company Information
7.22.2 LIBP Introduction and Business Overview
7.22.3 LIBP Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 LIBP Anti-aging Drugs Product Offerings
7.22.5 LIBP Recent Development
7.23 US World Meds
7.23.1 US World Meds Company Information
7.23.2 US World Meds Introduction and Business Overview
7.23.3 US World Meds Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 US World Meds Anti-aging Drugs Product Offerings
7.23.5 US World Meds Recent Development
7.24 Daewoong
7.24.1 Daewoong Company Information
7.24.2 Daewoong Introduction and Business Overview
7.24.3 Daewoong Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 Daewoong Anti-aging Drugs Product Offerings
7.24.5 Daewoong Recent Development
7.25 JETEMA
7.25.1 JETEMA Company Information
7.25.2 JETEMA Introduction and Business Overview
7.25.3 JETEMA Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 JETEMA Anti-aging Drugs Product Offerings
7.25.5 JETEMA Recent Development
8 Industry Chain Analysis
8.1 Anti-aging Drugs Industrial Chain
8.2 Anti-aging Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-aging Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Anti-aging Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

Contact Us:

Arshad Shaha | Marketing Executive

QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - arshad@qyrindia.com
Web - https://www.qyresearch.in

This release was published on openPR.